Enteropathic Spondyloarthritis
Enteropathic
arthritis (EA) is a spondyloarthritis (SpA) in patients with inflammatory diseases of the intestine (IBDs) and other gastrointestinal diseases. Diagnosis of medical
history and physical examination is generally established. It was made, generally, according to the criteria of the European Spondyloarthropathy Study Group (ESSG). Rheumatic manifestations are the most frequent findings of IBD with a prevalence of 17% to 39%, and IBD is less frequently associated with other rheumatic diseases such as rheumatoid arthritis, Sjogren syndrome, Takayasu arteritis, and fibromyalgia. The multidisciplinary management of eSpA patients, favored by this web-based platform created ad hoc, has allowed data to be obtained from the largest eSpA cohort. The
information coming from this database could advance eSpA knowledge and improve its standard of care. Some researchers believe the long-lasting
inflammation found in the intestines of people with IBD is damaging to the intestines, which in turn can allow bacteria to enter the damaged bowel wall and circulate through the bloodstream. The reaction of the body to these bacteria can cause other problems, including joint and/or spine inflammation, skin sores, and eye inflammation. This hypothesis is currently neither fully understood nor confirmed by rigorous scientific research. Spondyloarthritis diseases tend to occur in families, therefore there is also a genetic factor involved. Those testing positive for the
genetic marker HLA-B27 are much more likely to have a spinal involvement with EnA than those testing negative.
High Impact List of Articles
Relevant Topics in